Stephen C. Glover - May 18, 2023 Form 3 Insider Report for Ambrx Biopharma Inc. (AMAM)

Role: Director
Signature: /s/ Sonja Nelson, Attorney-in-Fact for Stephen C. Glover
Stock symbol: AMAM
Transactions as of: May 18, 2023
Transactions value $: $0
Form type: 3
Date filed: 5/19/2023, 04:05 PM
Previous filing: Dec 13, 2022
Next filing: Jul 18, 2024

No securities are beneficially owned.

Remarks:

See Exhibit 24 for power of attorney.